News

Why chaperones favor basic residues
3 April 2020
Chaperones are essential for proper protein folding. A Leuven research team now shows how the preference of chaperones for basic residues came about.
University hospital Ghent and VIB are testing medication to treat COVID-19-associated respiratory illness
24 March 2020
University Hospital Ghent and VIB are assessing a drug called Leukine® to treat patients with respiratory illness associated with COVID-19.
Battle Robots of the Blood
23 March 2020
Adrian Liston teamed up with illustrator Sonia Agüera-Gonzalez to tell the story of Tim, a regular 7-year-old boy, who happens to have a primary immunodeficiency.
From brilliant ideas to a successful biotech company
20 March 2020
Academic discoveries that are translated to the clinic improve patients’ quality of life and add value to healthcare systems around the world. For us, this is the real meaning of ‘giving back to society’.
Alzheimer risk genes converge on microglia
18 March 2020
Team led by Bart De Strooper (VIB-KU Leuven) and Mark Fiers show that many of risk factors affect brain maintenance cells called microglia & more particularly their response to amyloid-beta.
A protein that controls inflammation
17 March 2020
A study by the research team of Geert van Loo (VIB-UGent Center for Inflammation Research) has unraveled a critical molecular mechanism behind autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn’s disease, and psoriasis.
VIB achieves important milestone in the development of a COVID-19 drug
16 March 2020
The team of Xavier Saelens (VIB-UGent) has now established that the antibody can neutralize a lab variant of the virus, an important step forward in the development of a potential antiviral drug against the new coronavirus.
Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets
5 March 2020
Orionis Biosciences is debuting with the announcement of a major drug discovery collaboration with Novartis. Orionis has developed innovative technologies in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities.
The first Cell Atlas for the human Thymus
28 February 2020
Scientists from the VIB Center for Inflammation Research, Ghent University, The Wellcome Sanger Institute (UK), and Newcastle University (UK) have composed a complete map of the cells in the developing human thymus.
Essential oil components can be tested as drug candidates
21 February 2020
A research team at the VIB-KU Leuven Center for Microbiology and the KU Leuven Department of Biology showed that, contrary to generally held belief, most components of essential oils could meet the criteria set for drug candidates.
VIB and KU Leuven announce spin-off Montis Biosciences with a novel approach to immune-oncology
20 February 2020
Montis Biosciences announces its launch with €8,4 million in seed financing from an international investor syndicate to investigate interactions between perivascular macrophages and tumor vasculature.
VIB, KU Leuven and UGent announce new spin-off MRM Health to redefine microbiome-based therapeutics
19 February 2020
MRM Health enters into its first industry collaboration with DuPont Nutrition & Biosciences and boosts its development with an investment of more than €14 million to redefine microbiome-based therapeutics
VIB works on antiviral drug aimed to halt coronavirus outbreak
10 February 2020
As the outbreak of coronavirus continues to spread, VIB scientists are quickly mobilizing to try to find a potential treatment for the viral infection. Xavier Saelens and team (VIB-UGent) is well positioned to help meet the needs of this global crisis.
Novelty speeds up learning thanks to dopamine activation
5 February 2020
Brain scientists led by Sebastian Haesler (NERF, empowered by imec, KU Leuven and VIB) identified a causal mechanism of how novel stimuli promote learning. Novelty directly activates the dopamine system, which is responsible for associative learning.
Scientists develop ‘Twitter’ for cells
10 January 2020
Computational biologists led by Yvan Saeys (VIB-UGent) developed new bioinformatics method to better study communication between cells. This helps researchers to gain insight into how the gene expression of cells is regulated by interacting cells.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS